John Simmerling

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

May, 2025

John Simmerling

Jan 12, 2025, 19:40 | Blog

John Simmerling: How cancer cells find ways to evade the human immune system

John Simmerling, Chief Science Officer at Biomedical and Healthcare Technology Solutions Group, shared on LinkedIn:…

Jan 5, 2025, 14:12 | Blog

Strategies to reduce T-cell exhaustion in targeted immunotherapies

John Simmerling, Chief Science Officer at Biomedical and Healthcare Technology Solutions Group, shared a post…

Jan 4, 2025, 16:32 | Insight

John Simmerling: Amazing molecular animation video on an activated T-cell engaging with a diseased cell

John Simmerling, Chief Science Officer at Biomedical and Healthcare Technology Solutions Group, shared a post…

Dec 23, 2024, 15:38 | Insight

John Simmerling: An incredible microscopy of a ferocious, activated T-cell, killing a cancer cell

John Simmerling, Chief Science Officer at Biomedical and Healthcare Technology Solutions Group, shared a post…

All: 4 Posts: 1 - 100

'

Francesco Acerbi and Testicular Cancer: The Defender's Fight and Triumphant Return to Football

'

Yvonne Award for Breakthrough Research 2024 Recipient to Time100 Health List

'

Dr Saunthari Somasundaram is the new President-Elect of the NCD Alliance

'

Does Plastic Cause Cancer? Myths and Facts

'

TOPGEAR trial at ESTRO 2025: Preoperative Chemoradiotherapy for Resectable Gastric Cancer

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023